Focus Reports, Global
The Single User License (SUL) authorizes a single individual to use the electronic study acquired. Agreement to the SUL is required in order to purchase the study. If you require more than one user a Departmental Site License or Global Site License should be purchased.
The Departmental Site License (DSL) authorizes up to five users to share the study acquired. Agreement to the DSL is required in order to purchase the study. If your organization requires more than five users, the Global Site License should be purchased.
The Global Site License (GSL) allows everyone in your organization to share the study intelligence. Agreement to the Global Site License terms is necessary in order to purchase it.
This report forecasts to 2027 global sales of scientific and technical (S&T) publishing by product form in nominal US dollars.
Simba Information’s report details the trends impacting the market, profiles leading scientific and technical publishers, identifies mergers, and acquisitions that have occurred in the market from 2023-2024, and provides a global forecast of the sector.
This report forecasts for 2023 and 2027 US veterinary sector revenues in nominal US dollars.
This report explains the origins of the open access movement, gives a timeline for its development, but most importantly, Simba Information quantifies open access’ position as a fast growing subsegment of scholarly journal publishing.
Functional Beverages: Market Trends and Opportunities is the go-to source for a complete understanding of U.S. consumer trends regarding functional beverages.
This report provides annual forecasts to 2027 for US kidney dialysis center revenues in nominal US dollars.
According to Simba Information’s Global Social Sciences & Humanities Publishing 2023-2027 report, published June 2023, the global Social Science and Humanities market totaled $4.49 billion in revenue in 2022 an increase of 0.8% over $4.46 billion in 2021.
This report forecasts US pet medication retail sales in nominal US dollars for 2023-2027.
The pet medications market, 2020 and 2021 were boom years, but the market’s lackluster 3.7% growth during 2022 is actually indicative of unit sales losses stemming from higher prices, fewer veterinary visits, and a declining dog population.
This report forecasts to 2023 and 2027 revenues for US electronic health records (EHRs) in nominal US dollars.